My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?

    Fillmore C, Kuperwasser C.

    Breast Cancer Res. 2007;9(3):303.

    PMID:
    17540049
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.

    Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L.

    Breast Cancer Res. 2008;10(1):R10. Epub 2008 Feb 1.

    PMID:
    18241344
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    3.

    [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].

    Li Z, Liu CP, He YL, Tian Y, Huang T.

    Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;39(4):547-9. Chinese.

    PMID:
    18798490
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.

    Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.

    Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.

    PMID:
    19080260
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    5.

    Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.

    Fillmore CM, Kuperwasser C.

    Breast Cancer Res. 2008;10(2):R25. Epub 2008 Mar 26.

    PMID:
    18366788
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    6.

    CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.

    Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H.

    Breast Cancer Res. 2006;8(5):R59.

    PMID:
    17062128
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    7.

    Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

    Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.

    Clin Cancer Res. 2009 Jun 15;15(12):4234-41. Epub 2009 Jun 9.

    PMID:
    19509181
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    8.

    Breast cancer stem cells and intrinsic subtypes: controversies rage on.

    Nakshatri H, Srour EF, Badve S.

    Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. Review.

    PMID:
    19149630
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Identification of pancreatic cancer stem cells.

    Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM.

    Cancer Res. 2007 Feb 1;67(3):1030-7.

    PMID:
    17283135
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    10.

    The CD44+/CD24- phenotype is enriched in basal-like breast tumors.

    Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C.

    Breast Cancer Res. 2008;10(3):R53. Epub 2008 Jun 17.

    PMID:
    18559090
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    11.

    Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.

    Kai M, Onishi H, Souzaki M, Tanaka H, Kubo M, Tanaka M, Katano M.

    Cancer Sci. 2011 Dec;102(12):2132-8. doi: 10.1111/j.1349-7006.2011.02063.x. Epub 2011 Sep 14.

    PMID:
    21838786
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

    Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG.

    Cancer Res. 2005 Jul 1;65(13):5506-11.

    PMID:
    15994920
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    13.

    CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.

    Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL.

    Br J Cancer. 2008 Feb 26;98(4):756-65. Epub 2008 Feb 12.

    PMID:
    18268494
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    14.

    The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

    Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, Wu Z, Gönen M, Mulvey LA, Bessarabova MO, Huh SJ, Silver SJ, Kim SY, Park SY, Lee HE, Anderson KS, Richardson AL, Nikolskaya T, Nikolsky Y, Liu XS, Root DE, Hahn WC, Frank DA, Polyak K.

    J Clin Invest. 2011 Jul;121(7):2723-35. doi: 10.1172/JCI44745.

    PMID:
    21633165
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    15.

    Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.

    Zhang Y, Yao F, Yao X, Yi C, Tan C, Wei L, Sun S.

    Oncol Rep. 2009 Apr;21(4):1113-21.

    PMID:
    19288016
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells.

    Eriksson M, Guse K, Bauerschmitz G, Virkkunen P, Tarkkanen M, Tanner M, Hakkarainen T, Kanerva A, Desmond RA, Pesonen S, Hemminki A.

    Mol Ther. 2007 Dec;15(12):2088-93. Epub 2007 Sep 11.

    PMID:
    17848962
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Recent translational research: stem cells as the roots of breast cancer.

    Chang CC.

    Breast Cancer Res. 2006;8(1):103. Epub 2006 Feb 24.

    PMID:
    16524453
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    18.

    Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.

    Deng T, Liu JC, Pritchard KI, Eisen A, Zacksenhaus E.

    Clin Cancer Res. 2009 Jan 1;15(1):119-30.

    PMID:
    19118039
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    19.

    Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.

    Huang P, Wang CY, Gou SM, Wu HS, Liu T, Xiong JX.

    World J Gastroenterol. 2008 Jun 28;14(24):3903-7.

    PMID:
    18609717
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    20.

    Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.

    Bauerschmitz GJ, Ranki T, Kangasniemi L, Ribacka C, Eriksson M, Porten M, Herrmann I, Ristimäki A, Virkkunen P, Tarkkanen M, Hakkarainen T, Kanerva A, Rein D, Pesonen S, Hemminki A.

    Cancer Res. 2008 Jul 15;68(14):5533-9.

    PMID:
    18632604
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk